We are looking forward to a lively discussion tomorrow during our session” Will TLV‘s new framework strengthen access to orphan drugs” lead by Konstantin Macheridis, a parallel discussion to Quantify’s contributions to the EFPIA – European Federation of Pharmaceutical Industries and Associations‘ W.A.I.T. report in collaboration with Lif – de forskande läkemedelsföretagen.
Looking forward to seeing you there!
Hannah Norman, Linnea Oldsberg, Konstantin Macheridis, Isabelle Axelsson, and Lena Jacobs
